Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 307

Related Citations for PubMed (Select 9663626)

1.
2.

The legality of selling or giving syringes to injection drug users.

Burris S, Vernick JS, Ditzler A, Strathdee S.

J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6 Suppl 2):S13-8.

PMID:
12489604
3.

Access to sterile syringes in Maine: pharmacy practice after the 1993 repeal of the syringe prescription law.

Case P, Beckett GA, Jones TS.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S94-101.

PMID:
9663631
4.

Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers' practices.

Wright-De Ag├╝ero L, Weinstein B, Jones TS, Miles J.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S102-10.

PMID:
9663632
5.

State syringe and drug possession laws potentially influencing safe syringe disposal by injection drug users.

Burris S, Welsh J, Ng M, Li M, Ditzler A.

J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6 Suppl 2):S94-8.

PMID:
12489625
6.
7.

Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US.

Taussig JA, Weinstein B, Burris S, Jones TS.

AIDS. 2000 Jun;14 Suppl 1:S47-51.

PMID:
10981474
8.

Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States.

Holtgrave DR, Pinkerton SD, Jones TS, Lurie P, Vlahov D.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S133-8.

PMID:
9663636
9.

Arrests and incarceration of injection drug users for syringe possession in Massachusetts: implications for HIV prevention.

Case P, Meehan T, Jones TS.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S71-5.

PMID:
9663627
11.

Community-based programs for safe disposal of used needles and syringes.

Macalino GE, Springer KW, Rahman ZS, Vlahov D, Jones TS.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S111-9. Review.

PMID:
9663633
12.

Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut.

Singer M, Baer HA, Scott G, Horowitz S, Weinstein B.

Public Health Rep. 1998 Jun;113 Suppl 1:81-9.

13.

The role of needle exchange programs in HIV prevention.

Vlahov D, Junge B.

Public Health Rep. 1998 Jun;113 Suppl 1:75-80. Review.

14.

The needle-borne HIV epidemic: causes and public health responses.

Gostin L.

Behav Sci Law. 1991 Summer;9(3):287-304.

PMID:
10148824
15.

Syringe distribution to injection drug users for prevention of HIV infection: opinions and practices of health care providers in New York City.

Coffin PO, Fuller C, Blaney S, Vadnai L, Miller S, Vlahov D.

Clin Infect Dis. 2004 Feb 1;38(3):438-41. Epub 2004 Jan 13.

16.

Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.

Bluthenthal RN, Malik MR, Grau LE, Singer M, Marshall P, Heimer R; Diffusion of Benefit through Syringe Exchange Study Team.

Addiction. 2004 Sep;99(9):1136-46.

PMID:
15317634
17.

The impact of legalizing syringe exchange programs on arrests among injection drug users in California.

Martinez AN, Bluthenthal RN, Lorvick J, Anderson R, Flynn N, Kral AH.

J Urban Health. 2007 May;84(3):423-35.

18.

A national physician survey on prescribing syringes as an HIV prevention measure.

Macalino GE, Sachdev DD, Rich JD, Becker C, Tan LJ, Beletsky L, Burris S.

Subst Abuse Treat Prev Policy. 2009 Jun 8;4:13. doi: 10.1186/1747-597X-4-13.

19.

Pharmacists' attitudes about pharmacy sale of needles/syringes and needle exchange programs in a city without needle/syringe prescription laws.

Gleghorn AA, Gee G, Vlahov D.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S89-93.

PMID:
9663630
20.

An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users.

Lurie P, Gorsky R, Jones TS, Shomphe L.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S126-32.

PMID:
9663635
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk